The multi-partner team will integrate new technologies across the entire mAb production workflow, from cell line development to purification
Expands bioprocessing footprint across Asia
The partnership targets breakthroughs in Alzheimer’s disease, diabetes, cancer, and cell and gene therapy
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
Itvisma is a one-time, fixed-dose therapy designed to tackle the genetic root cause of SMA
The new Bioprocess Design Center will serve as a cutting-edge scale-up hub for biologics and vaccine manufacturing
Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
This is the first industry-academia collaboration in the country, initiated through the CSR route, for advancing research in the areas of immuno-therapeutics and regenerative medicines
Telangana aims to increase the value of the Life Sciences economy from US$ 80 billion to US$ 250 billion by 2030
Subscribe To Our Newsletter & Stay Updated
